DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer |
| |
Authors: | Ying Chen Muxing Kang Wenjie Lu Qingqu Guo Bo Zhang Qiuping Xie Yulian Wu |
| |
Institution: | Department of Surgery, Second Affiliated Hospital, College of Medicine, Cancer Institute of Zhejiang University, Zhejiang University, #88 Jiefang Road, Hangzhou, 310009, Zhejiang Province, People's Republic of China. |
| |
Abstract: | Purpose Aberrant expression of DJ-1 has been proven to be associated with tumorigenesis in many carcinomas. However, its role in pancreatic cancer is unknown. The aims of this study were to investigate whether the serum DJ-1 might be a potential biomarker for pancreatic cancer and to determine the biologic function of DJ-1 expression in gemcitabine-induced chemoresistance of pancreatic cancer. Methods The serum level of DJ-1 was higher in 128 pancreatic cancer patients compared with 62 healthy controls by ELISA. To determine the effect of DJ-1 on pancreatic tumor chemoresistance, a siRNA-targeting DJ-1 was synthesized and a stably transfected cell line with DJ-1 over-expression was constructed. The mechanism of tumor chemoresistance was assessed by multiple methods, such as MTT assay, real-time PCR, Western blot and flow cytometry. Results The serum level of DJ-1 was higher in pancreatic cancer patients than healthy controls, and it has the relationship with tumor differentiation in pancreatic cancer. Down-regulation of DJ-1 enhanced gemcitabine-induced apoptosis in three pancreatic cancer cell lines. On the contrary, over-expression of DJ-1 desensitized the MIA PaCa-2 to the induction of apoptosis by gemcitabine. Conclusions Our results suggest that the serum level of DJ-1 may be a potential biomarker for pancreatic cancer, and that DJ-1 plays critical roles in the pancreatic tumor chemoresistance, supporting the development of chemotherapeutic approaches targeting this oncogene. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|